- Home
- About Us
- Diabetes
- Research
- Medical Services
- Operations
- Internship & Training
- RFP
- Careers
- SUBSCRIBE
Dr. Hend AlQaderi wins L’Oréal-UNESCO Women in Science Young Talents Award
Dr. Hend AlQaderi was honored for her phenomenal research on the use of oral fluids as a non-invasive diagnostic tool for early diagnosis and disease management of COVID-19 and other inflammatory dis ...
Improved Testing for Inherited Diabetes Needed
More widespread knowledge of maturity-onset diabetes of the young (MODY) is required so that patients get the best treatment and management possible.
Alanbaa- DDI’s researchers stress the importance of the COVID-19 booster shot
...
AlAnba: DDI wins the UN Interagency Task Force on prevention of NCD’s, prestigious award for its efforts in addressing diabetes and its complications
AlSeyasah: DDI wins the UN Interagency Task Force on prevention of NCD’s, prestigious award for its efforts in addressing diabetes and its complications
AlNahar: DDI wins the UN Interagency Task Force on prevention of NCD’s, prestigious award for its efforts in addressing diabetes and its complications
Kuwait Times: DDI wins the UN Interagency Task Force on prevention of NCD’s, prestigious award for its efforts in addressing diabetes and its complications
AlKuwaitiya: DDI wins the UN Interagency Task Force on prevention of NCD’s, prestigious award for its efforts in addressing diabetes and its complications
AlQabas: DDI wins the UN Interagency Task Force on prevention of NCD’s, prestigious award for its efforts in addressing diabetes and its complications
Times: DDI wins the UN Interagency Task Force on prevention of NCD’s, prestigious award for its efforts in addressing diabetes and its complications
AlWasat: DDI wins the UN Interagency Task Force on prevention of NCD’s, prestigious award for its efforts in addressing diabetes and its complications
DDI was granted fourth patent for 2021
DDI’s researchers were granted the 4th patent of 2021 by the U.S. Patent & Trademark Office for our new invention on “Methods of Inhibiting MMP-9” by our DDI Inventors from the departme ...
DDI granted 3rd patent right!
The Biochemistry and Molecular Biology researchers were granted the U.S. patent rights on our new invention “MicroRNA ANGPTL3 INHIBITOR”on 13th July 2021. The patent was ultimately issued from t ...
DDI’s researchers on #1 show in Kuwait
DDI’s researchers were invited to the #1 show on KTV1 ‘Layali AlKuwait’ to discuss the latest research acheivments and findings. Dr. Faisal Al-Rifai, Chief Operating Officer, Dr. Da ...
Biochemistry and Molecular Biology Unit are granted a patent
The DDI “Patent and Research Translation Committee” congratulates the researchers on the grant of U.S. patent on our new invention “Use of MicroRNA-103 as Inhibitor for dyslipidemia by rep ...
© 2022 Dasman Diabetes Institute. All rights reserved.